#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyloidosis Endocrine ophthalmopathy Heavy menstrual bleeding Scleroderma associated digital ulcer Hereditary haemorrhagic telangiectasia Cholestatic pruritus Infertility male Neurotrophic keratopathy Central nervous system lymphoma Biliary neoplasm Colitis ulcerative Hyperinsulinism Neuroendocrine carcinoma metastatic Pseudoxanthoma elasticum Ductal adenocarcinoma of pancreas More trials…

    Learn about Rare Diseases

    Angiosarcoma metastatic – Treatment Primary biliary cholangitis – Trials in Disease Leukoencephalopathy Turner’s syndrome – Diagnostics Alport’s syndrome – Treatment Castleman’s disease – Trials in Disease Angiosarcoma Chordoma Gastrointestinal stromal tumour – Treatment Myxofibrosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Emactuzumab Tasipimidine Ladarixin Tenofovir Alafenamide Chlorpromazine Treprostinil Sodium Ecubectedin Cytarabine Etuvetidigene Autotemcel Emedastine Ublituximab Tarlatamab Ligelizumab Gsk3915393 Ecoo25B Elritercept Pimozide Histidine Acoramidis Hydrochloride L-Glutamic Acid More therapies…

    Learn about Your Condition

    Thyroid mass Rectal neoplasm Vaginal infection Dyspepsia Hypopituitarism Femoral hernia Hypertonic bladder Carotid artery stenosis Hyperphagia Cough Renal cancer recurrent Hyperkalaemia Pulmonary congestion Aphthous ulcer Sarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. HeiligHartziekenhuis Lier

HeiligHartziekenhuis Lier

Mechelsestraat 24, Lier, 2500, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Abiraterone
    • Apalutamide
    • Darolutamide
    Belgium Croatia Czechia Denmark France Ireland +4

  • Study on Opioid Detoxification Using Buprenorphine, Naloxone, and Oxycodone for Patients with Persistent Spinal Pain Syndrome Type II

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Buprenorphine
    • Clonidine Hydrochloride
    • Naloxone
    Belgium

  • Study of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Cyclophosphamide
    • Docetaxel
    Belgium France Germany Italy Poland Portugal +1

  • Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety

    Not recruiting

    3 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    Belgium Czechia Germany Hungary Italy Poland +4

  • Study on Subcutaneous Infliximab for Patients with Ulcerative Colitis, Crohn’s Disease, or Unclassified Inflammatory Bowel Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Inflammatory bowel disease
    • Crohn’s disease
    Investigated Drugs:
    • Infliximab
    Belgium

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!